SCHEMBL7700513

SCHEMBL7700513

CCOC(=O)C(C)C(O)c1ccc(Nc2nc3ccccc3s2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.56
RAB9A P51151 9/20 0.56
SMN1; SMN2 Q16637 7/20 0.56
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
MAPT P10636 4/20 0.55
MAPK1 P28482 2/20 0.53
NFKB1 P19838 2/20 0.52
NFKB2 Q00653 2/20 0.52
RELA Q04206 2/20 0.52
POLB P06746 1/20 0.52
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HTT P42858 1/20 0.51
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
CYP26A1 O43174 6/20 0.49
GAA P10253 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988336 0.86 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4988013 0.82 CYP26A1 (0.62) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4981777 0.81 RAB9A (0.62) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4986438 0.79 CYP26A1 (0.57) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4986984 0.78 CYP26A1 (0.64) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL13002093 0.74 NPC1 (0.62) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL29369155 0.74 KMT2A (0.72) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL8023816 0.74 HDAC6 (0.63) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5022950 0.74 KMT2A (0.72) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL13002103 0.74 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486187-B1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines JANSSEN PHARMACEUTICA N.V. (BE) 2002-11-26 US disclosed